GlassScriptPhysician profile
Joseph S Wong
NPI 1760484976
$6,981.53
in general payments reported to CMS, 2019-2025
18 companies · $4,074 in 2025
The $4,074 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $167 · 2022: $1,756 · 2023: $413 · 2024: $283 · 2025: $4,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,714 · Food and Beverage: $2,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,714.49 |
| Food and Beverage | $2,055.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,083.22 | 2022-2025 | Farapulse, Endotak Reliance S, General - Therapies |
| Medtronic, INC. | $1,244.50 | 2022-2024 | Pulseselect |
| Abbott Laboratories | $842.87 | 2019-2025 | Aveir |
| Philips North America LLC | $769.44 | 2025 | Igt Devices Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.78 | 2020-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $172.11 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.12 | 2022 | |
| Pfizer INC. | $114.27 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $95.55 | 2023 | Optimizer |
| Cvrx, INC. | $44.62 | 2022-2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $43.79 | 2022-2024 | |
| Novo Nordisk INC | $37.83 | 2022 | |
| Medtronic Vascular, INC. | $34.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.18 | 2022 | |
| Kestra Medical Technology Services, INC. | $31.47 | 2025 | Assure Wcd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $30.19 | 2025 | |
| Daiichi Sankyo INC. | $27.71 | 2024 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $25.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.